ASTELLAS PHARMA UNSP.ADR (YPHA) — Cash Flow-to-Debt Ratio
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow-to-Debt Ratio of 0.11x as of March 2025, meaning its operating cash flow of €194.51 Billion could theoretically repay 0% of its total liabilities (€1.83 Trillion) in one year. See ASTELLAS PHARMA UNSP.ADR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ASTELLAS PHARMA UNSP.ADR Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Also explore ASTELLAS PHARMA UNSP.ADR (YPHA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year debt coverage analysis for ASTELLAS PHARMA UNSP.ADR. For market capitalisation and broader financial context, see ASTELLAS PHARMA UNSP.ADR stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | €194.51 Billion | €1.83 Trillion | ▲ +21.9% |
| 2024 | 0.09x | €172.47 Billion | €1.97 Trillion | ▼ -74.7% |
| 2023 | 0.35x | €327.77 Billion | €948.56 Billion | ▲ +17.1% |
| 2022 | 0.30x | €257.44 Billion | €872.09 Billion | — |